Trexquant Investment’s BELLUS Health Inc. BLU Stock Holding History

Trexquant Investment’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-17,778	Closed	-$143K	–	1838
2021 Q4	$143K	Buy	+17,778	New	+$118K	0.01%	1196

Other funds holding BLU

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Trexquant Investment's BLU Position: Q1 2022 in Review

Trexquant Investment sold out of BELLUS Health Inc. (BLU) in Q1 2022, closing a stake of 17,778 shares — an estimated $143K sold.

Trexquant Investment first reported a position in BLU in Q4 2021 and held it in 1 quarter. The position peaked at $143K in Q4 2021. 77 funds tracked by Wall St. Rank hold BLU as of Q1 2022.

Trexquant Investment reported no remaining BELLUS Health Inc. position as of Q1 2022 after selling out during the quarter.
Trexquant Investment sold 17,778 BELLUS Health Inc. shares in Q1 2022, an estimated $143K.
Trexquant Investment first reported a position in BELLUS Health Inc. in Q4 2021 and held it in 1 quarter.
Trexquant Investment's BELLUS Health Inc. position peaked at $143K in Q4 2021.
77 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2022.

Based on Trexquant Investment's 13F filing for Q1 2022, filed 13 May 2022.